Correlation Between Large-cap Growth and Pharmaceuticals Ultrasector

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Large-cap Growth and Pharmaceuticals Ultrasector at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Large-cap Growth and Pharmaceuticals Ultrasector into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Large Cap Growth Profund and Pharmaceuticals Ultrasector Profund, you can compare the effects of market volatilities on Large-cap Growth and Pharmaceuticals Ultrasector and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Large-cap Growth with a short position of Pharmaceuticals Ultrasector. Check out your portfolio center. Please also check ongoing floating volatility patterns of Large-cap Growth and Pharmaceuticals Ultrasector.

Diversification Opportunities for Large-cap Growth and Pharmaceuticals Ultrasector

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Large-cap and Pharmaceuticals is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Large Cap Growth Profund and Pharmaceuticals Ultrasector Pr in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pharmaceuticals Ultrasector and Large-cap Growth is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Large Cap Growth Profund are associated (or correlated) with Pharmaceuticals Ultrasector. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pharmaceuticals Ultrasector has no effect on the direction of Large-cap Growth i.e., Large-cap Growth and Pharmaceuticals Ultrasector go up and down completely randomly.

Pair Corralation between Large-cap Growth and Pharmaceuticals Ultrasector

If you would invest  3,837  in Large Cap Growth Profund on April 19, 2025 and sell it today you would earn a total of  1,127  from holding Large Cap Growth Profund or generate 29.37% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy0.0%
ValuesDaily Returns

Large Cap Growth Profund  vs.  Pharmaceuticals Ultrasector Pr

 Performance 
       Timeline  
Large Cap Growth 

Risk-Adjusted Performance

Very Strong

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Large Cap Growth Profund are ranked lower than 33 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly weak forward indicators, Large-cap Growth showed solid returns over the last few months and may actually be approaching a breakup point.
Pharmaceuticals Ultrasector 

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Over the last 90 days Pharmaceuticals Ultrasector Profund has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong forward indicators, Pharmaceuticals Ultrasector is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Large-cap Growth and Pharmaceuticals Ultrasector Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Large-cap Growth and Pharmaceuticals Ultrasector

The main advantage of trading using opposite Large-cap Growth and Pharmaceuticals Ultrasector positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Large-cap Growth position performs unexpectedly, Pharmaceuticals Ultrasector can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pharmaceuticals Ultrasector will offset losses from the drop in Pharmaceuticals Ultrasector's long position.
The idea behind Large Cap Growth Profund and Pharmaceuticals Ultrasector Profund pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.

Other Complementary Tools

Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Money Managers
Screen money managers from public funds and ETFs managed around the world
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
CEOs Directory
Screen CEOs from public companies around the world